149 related articles for article (PubMed ID: 35491292)
1. Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series.
Isoardi KZ; Parker L; Harris K; Rashford S; Isbister GK
Ann Emerg Med; 2022 Aug; 80(2):120-126. PubMed ID: 35491292
[TBL] [Abstract][Full Text] [Related]
2. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
Kim HK; Nelson LS
J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR
Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548
[TBL] [Abstract][Full Text] [Related]
5. Use and efficacy of nebulized naloxone in patients with suspected opioid intoxication.
Baumann BM; Patterson RA; Parone DA; Jones MK; Glaspey LJ; Thompson NM; Stauss MP; Haroz R
Am J Emerg Med; 2013 Mar; 31(3):585-8. PubMed ID: 23347721
[TBL] [Abstract][Full Text] [Related]
6. Hospital Observation Upon Reversal (HOUR) With Naloxone: A Prospective Clinical Prediction Rule Validation Study.
Clemency BM; Eggleston W; Shaw EW; Cheung M; Pokoj NS; Manka MA; Giordano DJ; Serafin L; Yu H; Lindstrom HA; Hostler D
Acad Emerg Med; 2019 Jan; 26(1):7-15. PubMed ID: 30592101
[TBL] [Abstract][Full Text] [Related]
7. Do heroin overdose patients require observation after receiving naloxone?
Willman MW; Liss DB; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
[TBL] [Abstract][Full Text] [Related]
8. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose.
Buajordet I; Naess AC; Jacobsen D; Brørs O
Eur J Emerg Med; 2004 Feb; 11(1):19-23. PubMed ID: 15167188
[TBL] [Abstract][Full Text] [Related]
9. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
Kelly AM; Kerr D; Dietze P; Patrick I; Walker T; Koutsogiannis Z
Med J Aust; 2005 Jan; 182(1):24-7. PubMed ID: 15651944
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.
Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; van Beek I; McGrath C; Kerr D
JAMA Netw Open; 2019 Nov; 2(11):e1914977. PubMed ID: 31722024
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
Facey C; Brooks D; Boland JW
Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
[TBL] [Abstract][Full Text] [Related]
12. Lack of respiratory depression in paracetamol-codeine combination overdoses.
Heppell SPE; Isbister GK
Br J Clin Pharmacol; 2017 Jun; 83(6):1273-1278. PubMed ID: 28035699
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for severe respiratory depression from prescription opioid overdose.
Fox LM; Hoffman RS; Vlahov D; Manini AF
Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
[TBL] [Abstract][Full Text] [Related]
14. Dedicated nursing care pathway improved management of opioid-poisoned patients in the emergency department: A before-after observational study.
Isoardi K; Learmont B; Horan B; Isbister G
Emerg Med Australas; 2023 Feb; 35(1):69-73. PubMed ID: 35970763
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
[TBL] [Abstract][Full Text] [Related]
16. Prospective multicenter evaluation of tramadol exposure.
Spiller HA; Gorman SE; Villalobos D; Benson BE; Ruskosky DR; Stancavage MM; Anderson DL
J Toxicol Clin Toxicol; 1997; 35(4):361-4. PubMed ID: 9204095
[TBL] [Abstract][Full Text] [Related]
17. The effect of a low-dose naloxone infusion on the incidence of respiratory depression after intrathecal morphine administration for major open hepatobiliary surgery: a randomised controlled trial.
Cosgrave D; Vencken S; Galligan M; McGuinness S; Soukhin E; McMullan V; Nair S; Puttappa A; Boylan J; Hussain R; Conlon N; Doran P; Nichol A
Anaesthesia; 2020 Jun; 75(6):747-755. PubMed ID: 31792949
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
Zamani N; Hassanian-Moghaddam H
Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
[TBL] [Abstract][Full Text] [Related]
19. Use of Naloxone in 9-1-1 Patients without Respiratory Depression in Los Angeles County, California (USA).
Jenkins C; Levine M; Sanko S; Kazan C; Thomas CE; Eckstein M
Prehosp Disaster Med; 2021 Oct; 36(5):543-546. PubMed ID: 34425934
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Two Naloxone Regimens in Opioid-dependent Methadoneoverdosed Patients: A Clinical Trial Study.
Khosravi N; Zamani N; Hassanian-Moghaddam H; Ostadi A; Rahimi M; Kabir A
Curr Clin Pharmacol; 2017; 12(4):259-265. PubMed ID: 29231146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
